|
|
|
Insider
Information: |
Brennan Daniel J. |
Relationship: |
Director |
City: |
Natick |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
272,248 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$20,017,565 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
272,248 |
|
|
Total
Value |
$20,017,565 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
Percentage
Gain/Loss : |
0.0%
|
11.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Boston Scientific Corp |
BSX |
EVP and CFO |
2024-02-20 |
271,542 |
|
0 |
Premium* |
|
Nuance Communications Inc |
NUAN |
Director |
2022-03-04 |
0 |
2018-09-10 |
0 |
Premium* |
|
Waters Corp |
WAT |
Director |
2024-01-02 |
706 |
2022-11-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
169 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2022-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,706 |
272,433 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2021-02-10 |
4 |
D |
$38.85 |
$261,072 |
D/D |
(6,720) |
272,718 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2022-02-21 |
4 |
D |
$42.55 |
$69,101 |
D/D |
(1,624) |
272,826 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2022-02-22 |
4 |
AS |
$42.75 |
$2,273,621 |
D/D |
(53,182) |
272,826 |
0 |
% |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2024-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,706 |
273,186 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2023-01-01 |
4 |
D |
$46.27 |
$187,023 |
D/D |
(4,042) |
273,382 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2018-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,365 |
274,392 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2022-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,661 |
274,450 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2021-02-15 |
4 |
D |
$38.39 |
$70,714 |
D/D |
(1,842) |
275,029 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2018-02-24 |
4 |
D |
$27.20 |
$69,333 |
D/D |
(2,549) |
275,192 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2022-02-15 |
4 |
D |
$44.01 |
$53,648 |
D/D |
(1,219) |
275,313 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2022-02-28 |
4 |
D |
$44.17 |
$87,810 |
D/D |
(1,988) |
275,319 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2021-03-02 |
4 |
AS |
$38.84 |
$368,034 |
D/D |
(9,475) |
275,370 |
0 |
% |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2023-02-15 |
4 |
AS |
$47.14 |
$356,927 |
D/D |
(7,572) |
276,316 |
0 |
% |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2022-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,193 |
276,436 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2022-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,153 |
276,532 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2021-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,153 |
276,871 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2021-02-18 |
4 |
D |
$37.52 |
$61,683 |
D/D |
(1,644) |
277,091 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2022-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,481 |
277,307 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2023-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,134 |
277,424 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2018-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,734 |
277,741 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2022-02-16 |
4 |
OE |
$6.28 |
$76,534 |
D/D |
12,187 |
278,364 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2024-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
36,666 |
278,404 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2021-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,706 |
278,735 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2021-02-21 |
4 |
D |
$38.03 |
$61,761 |
D/D |
(1,624) |
279,128 |
0 |
- |
|
169 Records found
|
|
Page 5 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|